| 1 | [SID85285636] | Active | IC50 | 8.6 | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 [AID2505, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Active | | IC50 | 8.6 [uM] | | BioAssay | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 | | AID | 2505 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 2 | [SID85285636] | Active | IC50 | 8.6 | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 [AID2505, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Active | | IC50 | 8.6 [uM] | | BioAssay | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 | | AID | 2505 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 3 | [SID85285636] | Active | IC50 | 8.6 | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 [AID2505, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Active | | IC50 | 8.6 [uM] | | BioAssay | SAR analysis of GM-Tri-DAP induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 | | AID | 2505 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 4 | [SID85285636] | Active | IC50 | 12.71 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Active | | IC50 | 12.71 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 5 | [SID85285636] | Active | IC50 | 12.71 | SAR analysis of compounds that inhibit NOD1 revised [AID2333, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Active | | IC50 | 12.71 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD1 revised | | AID | 2333 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 6 | [SID47203483] | Active | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 7 | [SID47203483] | Active | | | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624412, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Luminescence-based biochemical high throughput confirmation assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624412 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 8 | [SID47203483] | Active | | | Fluorescent Polarization-based biochemical high throughput orthogonal assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID651607, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Fluorescent Polarization-based biochemical high throughput orthogonal assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 651607 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 9 | [SID47203483] | Active | | | Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4). [AID2247, Type: screening] | alternatively spliced Trp4 [Mus musculus] [gi:2935630] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4). | | AID | 2247 | | BioAssay type | screening | | Target | alternatively spliced Trp4 [Mus musculus] [gi:2935630] | | PubMed | | | Data Table |  |
|
| 10 | [SID47203483] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 11 | [SID47203483] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 12 | [SID47203483] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID47203483] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 14 | [SID47203483] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 15 | [SID85285636] | Inactive | IC50 | 20 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 16 | [SID85285636] | Inactive | IC50 | 20 | SAR analysis of inhibitors of TNFa specific NF-kB induction revised [AID2337, Type: confirmatory] | TNF gene product [Homo sapiens] [gi:25952111] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of inhibitors of TNFa specific NF-kB induction revised | | AID | 2337 | | BioAssay type | confirmatory | | Target | TNF gene product [Homo sapiens] [gi:25952111] | | PubMed | | | Data Table |  |
|
| 17 | [SID85285636] | Inactive | IC50 | 20 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 18 | [SID85285636] | Inactive | IC50 | 20 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 19 | [SID85285636] | Inactive | IC50 | 20 | SAR analysis of compounds that inhibit NOD2 revised [AID2334, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that inhibit NOD2 revised | | AID | 2334 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 2 [Homo sapiens] [gi:11545912] | | PubMed | | | Data Table |  |
|
| 20 | [SID85285636] | Inactive | IC50 | 20 | SAR analysis of compounds that are cytotoxic to HEK293 revised [AID2335, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | SAR analysis of compounds that are cytotoxic to HEK293 revised | | AID | 2335 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID47203483] | Inactive | Potency | 22.3872 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of NF-kappaB dependent luciferase using Doxorucibin as an inducer - Set 2 [AID2789, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kappaB dependent luciferase using Doxorucibin as an inducer - Set 2 | | AID | 2789 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 23 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of NF-kappaB dependent luciferase using Doxorucibin as an inducer - Set 2 [AID2789, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kappaB dependent luciferase using Doxorucibin as an inducer - Set 2 | | AID | 2789 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 24 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of NF-kappaB dependent luciferase using PMA/Ionomycin as an inducer - 2 [AID2792, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kappaB dependent luciferase using PMA/Ionomycin as an inducer - 2 | | AID | 2792 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 25 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of NF-kappaB dependent luciferase using PMA/Ionomycin as an inducer - 2 [AID2792, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kappaB dependent luciferase using PMA/Ionomycin as an inducer - 2 | | AID | 2792 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 26 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of NF-kappaB dependent luciferase using DAP as an inducer - Set 2 [AID2793, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kappaB dependent luciferase using DAP as an inducer - Set 2 | | AID | 2793 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 27 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of NF-kappaB dependent luciferase using DAP as an inducer - Set 2 [AID2793, Type: confirmatory] | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of NF-kappaB dependent luciferase using DAP as an inducer - Set 2 | | AID | 2793 | | BioAssay type | confirmatory | | Target | nucleotide-binding oligomerization domain-containing protein 1 [Homo sapiens] [gi:5174617] | | PubMed | | | Data Table |  |
|
| 28 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of Muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells - Set 2 [AID2503, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of Muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells - Set 2 | | AID | 2503 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 29 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of Muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells - Set 2 [AID2503, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of Muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells - Set 2 | | AID | 2503 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 30 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of Muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells - Set 2 [AID2503, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of Muramyl dipeptide (MDP) induced IL-8 secretion in MCF-7/NOD2 cells - Set 2 | | AID | 2503 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 31 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of Tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 [AID2504, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of Tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 | | AID | 2504 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 32 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of Tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 [AID2504, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of Tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 | | AID | 2504 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 33 | [SID85285636] | Inactive | IC50 | 25 | SAR analysis of Tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 [AID2504, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85285636 | | CID | 761923 | | Outcome | Inactive | | IC50 | 25 [uM] | | BioAssay | SAR analysis of Tumor necrosis factor alpha (TNF-alpha) induced IL-8 secretion in MCF-7/NOD1 cells - Set 2 | | AID | 2504 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 34 | [SID47203483] | Inactive | Potency | 79.4328 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 35 | [SID47203483] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 36 | [SID47203483] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 37 | [SID47203483] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 38 | [SID47203483] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 39 | [SID47203483] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 40 | [SID47203483] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 41 | [SID47203483] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 42 | [SID47203483] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 43 | [SID47203483] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 44 | [SID47203483] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 45 | [SID47203483] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 46 | [SID47203483] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 47 | [SID47203483] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 48 | [SID47203483] | Inactive | IC50 | | Fluorescence for the identification of compounds that decrease p/CIP protein stability [AID1984, Type: confirmatory] | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Fluorescence for the identification of compounds that decrease p/CIP protein stability | | AID | 1984 | | BioAssay type | confirmatory | | Target | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] | | PubMed | | | Data Table |  |
|
| 49 | [SID47203483] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 50 | [SID47203483] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 47203483 | | CID | 761923 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|